Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery, clinical cancer research an official journal of the american association for
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.